System Transmission

Top Signal

100#1 JOB

Activity

2163Ripe

+917 today

System

Livenow

Terminal Asset View

stockNASDAQ

FHTX

$4.90-0.41%

Foghorn Therapeutics Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

54Overripe

Live Analysis Active

Company Mission

Foghorn Therapeutics creates experimental drugs that target specific proteins involved in controlling how genes work inside cells. These medicines are designed to treat cancers by interfering with the biological processes that allow cancer cells to grow. The company makes money through research collaborations with larger pharmaceutical companies and by advancing its own drug candidates through clinical testing.

FHT

Industry Context

The biotech industry focuses on developing new medical treatments using biological science. Companies in this space research drugs for diseases like cancer, often partnering with larger pharmaceutical firms to bring treatments to market. Targeted therapies that attack specific cancer mechanisms are a growing area of interest.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

74Matrix

Market Momentum

36.3— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

1.5x— Normal Volume

Today's Change

-0.41%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing FHTX across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 09:16 AM UTC

As-of 03-15-2026 09:01 UTC

Develops cancer drugs that target genetic switches and makes money by licensing treatments to pharmaceutical companies.

Weekly chart shows price ranges getting tighter, suggesting a coiling pattern that often comes before a big move.

Biotech sector showing increased interest in targeted cancer therapies, which could benefit companies with novel drug platforms.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...